Drugs Market Research Reports & Industry Analysis

The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.

Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.

A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.

Publications found: 9,295

Sort by:

Interleukin 18 (Interferon Gamma Inducing Factor or Iboctadekin or Interleukin 1 Gamma or IL18) - Drugs in Development, 2021

US$ 3,000.00

Interleukin 18 (Interferon Gamma Inducing Factor or Iboctadekin or Interleukin 1 Gamma or IL18) - Drugs in Development, 2021 SUMMARY Interleukin 18 (Interferon Gamma Inducing Factor or Iboctadekin or...

April 2021 35 pages

Interleukin 2 Receptor (IL2R) - Drugs in Development, 2021

US$ 3,000.00

Interleukin 2 Receptor (IL2R) - Drugs in Development, 2021 SUMMARY Interleukin 2 Receptor (IL2R) - Drugs in Development, 2021 provides in depth analysis on Interleukin 2 Receptor (IL2R) targeted pipel...

April 2021 70 pages

Interleukin 2 Receptor Subunit Alpha (TAC Antigen or p55 or CD25 or IL2RA) - Drugs in Development, 2021

US$ 3,000.00

Interleukin 2 Receptor Subunit Alpha (TAC Antigen or p55 or CD25 or IL2RA) - Drugs in Development, 2021 SUMMARY Interleukin 2 Receptor Subunit Alpha (TAC Antigen or p55 or CD25 or IL2RA) - Drugs in De...

April 2021 45 pages

Interleukin 2 (T Cell Growth Factor or Aldesleukin or IL2) - Drugs in Development, 2021

US$ 3,000.00

Interleukin 2 (T Cell Growth Factor or Aldesleukin or IL2) - Drugs in Development, 2021 SUMMARY Interleukin 2 (T Cell Growth Factor or Aldesleukin or IL2) - Drugs in Development, 2021 provides in dept...

April 2021 55 pages

Interleukin 21 Receptor (Novel Interleukin Receptor or CD360 or IL21R) - Drugs in Development, 2021

US$ 3,000.00

Interleukin 21 Receptor (Novel Interleukin Receptor or CD360 or IL21R) - Drugs in Development, 2021 SUMMARY Interleukin 21 Receptor (Novel Interleukin Receptor or CD360 or IL21R) - Drugs in Developmen...

April 2021 35 pages

Interleukin 22 Receptor (IL22R) - Drugs in Development, 2021

US$ 3,000.00

Interleukin 22 Receptor (IL22R) - Drugs in Development, 2021 SUMMARY Interleukin 22 Receptor (IL22R) - Drugs in Development, 2021 provides in depth analysis on Interleukin 22 Receptor (IL22R) targeted...

April 2021 35 pages

Interleukin 23 (IL23) - Drugs in Development, 2021

US$ 3,000.00

Interleukin 23 (IL23) - Drugs in Development, 2021 SUMMARY Interleukin 23 (IL23) - Drugs in Development, 2021 provides in depth analysis on Interleukin 23 (IL23) targeted pipeline therapeutics. The re...

April 2021 35 pages

Interleukin 23 Receptor (IL23R) - Drugs in Development, 2021

US$ 3,000.00

Interleukin 23 Receptor (IL23R) - Drugs in Development, 2021 SUMMARY Interleukin 23 Receptor (IL23R) - Drugs in Development, 2021 provides in depth analysis on Interleukin 23 Receptor (IL23R) targeted...

April 2021 35 pages

Interleukin 23 Subunit Alpha (Interleukin 23 Subunit p19 or IL23A) - Drugs in Development, 2021

US$ 3,000.00

Interleukin 23 Subunit Alpha (Interleukin 23 Subunit p19 or IL23A) - Drugs in Development, 2021 SUMMARY Interleukin 23 Subunit Alpha (Interleukin 23 Subunit p19 or IL23A) - Drugs in Development, 2021...

April 2021 50 pages

Interleukin 4 (B Cell Stimulatory Factor 1 or Binetrakin or Lymphocyte Stimulatory Factor 1 or Pitrakinra or IL4) - Drugs in Development, 2021

US$ 3,000.00

Interleukin 4 (B Cell Stimulatory Factor 1 or Binetrakin or Lymphocyte Stimulatory Factor 1 or Pitrakinra or IL4) - Drugs in Development, 2021 SUMMARY Interleukin 4 (B Cell Stimulatory Factor 1 or Bin...

April 2021 30 pages

Interleukin 4 Receptor Subunit Alpha (CD124 or IL4R) - Drugs in Development, 2021

US$ 3,000.00

Interleukin 4 Receptor Subunit Alpha (CD124 or IL4R) - Drugs in Development, 2021 SUMMARY Interleukin 4 Receptor Subunit Alpha (CD124 or IL4R) - Drugs in Development, 2021 provides in depth analysis o...

April 2021 45 pages

Interleukin 5 (Eosinophil Differentiation Factor or B Cell Differentiation Factor I or T Cell Replacing Factor or IL5) - Drugs in Development, 2021

US$ 3,000.00

Interleukin 5 (Eosinophil Differentiation Factor or B Cell Differentiation Factor I or T Cell Replacing Factor or IL5) - Drugs in Development, 2021 SUMMARY Interleukin 5 (Eosinophil Differentiation Fa...

April 2021 35 pages

Interleukin 6 Receptor (IL6R) - Drugs in Development, 2021

US$ 3,000.00

Interleukin 6 Receptor (IL6R) - Drugs in Development, 2021 SUMMARY Interleukin 6 Receptor (IL6R) - Drugs in Development, 2021 provides in depth analysis on Interleukin 6 Receptor (IL6R) targeted pipel...

April 2021 55 pages

Interleukin 7 (IL7) - Drugs in Development, 2021

US$ 3,000.00

Interleukin 7 (IL7) - Drugs in Development, 2021 SUMMARY Interleukin 7 (IL7) - Drugs in Development, 2021 provides in depth analysis on Interleukin 7 (IL7) targeted pipeline therapeutics. The report p...

April 2021 30 pages

Intermediate Conductance Calcium Activated Potassium Channel Protein 4 (KCa3.1 or Gardos Channel or KCNN4) - Drugs in Development, 2021

US$ 3,000.00

Intermediate Conductance Calcium Activated Potassium Channel Protein 4 (KCa3.1 or Gardos Channel or KCNN4) - Drugs in Development, 2021 SUMMARY Intermediate Conductance Calcium Activated Potassium Cha...

April 2021 35 pages

Intermediate Uveitis (Ophthalmology) - Drugs in Development, 2021

US$ 2,000.00

Intermediate Uveitis (Ophthalmology) - Drugs in Development, 2021 SUMMARY Intermediate Uveitis (Ophthalmology) - Drugs in Development, 2021 provides an overview of the Intermediate Uveitis pipeline la...

April 2021 35 pages

Interstitial Cystitis (Painful Bladder Syndrome/Bladder Pain Syndrome) (Genito Urinary System And Sex Hormones) - Drugs in Development, 2021

US$ 2,000.00

Interstitial Cystitis (Painful Bladder Syndrome/Bladder Pain Syndrome) (Genito Urinary System And Sex Hormones) - Drugs in Development, 2021 SUMMARY Interstitial Cystitis (Painful Bladder Syndrome/Bla...

April 2021 45 pages

Interstitial Lung Diseases (Diffuse Parenchymal Lung Disease) (Respiratory) - Drugs in Development, 2021

US$ 2,000.00

Interstitial Lung Diseases (Diffuse Parenchymal Lung Disease) (Respiratory) - Drugs in Development, 2021 SUMMARY Interstitial Lung Diseases (Diffuse Parenchymal Lung Disease) (Respiratory) - Drugs in...

April 2021 45 pages

Interstitial Lung Fibrosis (Respiratory) - Drugs in Development, 2021

US$ 2,000.00

Interstitial Lung Fibrosis (Respiratory) - Drugs in Development, 2021 SUMMARY Interstitial Lung Fibrosis (Respiratory) - Drugs in Development, 2021 provides an overview of the Interstitial Lung Fibros...

April 2021 30 pages

Intracerebral Hemorrhage (Central Nervous System) - Drugs in Development, 2021

US$ 2,000.00

Intracerebral Hemorrhage (Central Nervous System) - Drugs in Development, 2021 SUMMARY Intracerebral Hemorrhage (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Intrac...

April 2021 50 pages

Ischemia (Cardiovascular) - Drugs in Development, 2021

US$ 2,000.00

Ischemia (Cardiovascular) - Drugs in Development, 2021 SUMMARY Ischemia (Cardiovascular) - Drugs in Development, 2021 provides an overview of the Ischemia pipeline landscape. The report provides compr...

April 2021 65 pages

Ischemic Cardiomyopathy (Cardiovascular) - Drugs in Development, 2021

US$ 2,000.00

Ischemic Cardiomyopathy (Cardiovascular) - Drugs in Development, 2021 SUMMARY Ischemic Cardiomyopathy (Cardiovascular) - Drugs in Development, 2021 provides an overview of the Ischemic Cardiomyopathy...

April 2021 35 pages

Ischemic Stroke (Central Nervous System) - Drugs in Development, 2021

US$ 2,500.00

Ischemic Stroke (Central Nervous System) - Drugs in Development, 2021 SUMMARY Ischemic Stroke (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Ischemic Stroke pipeline...

April 2021 190 pages

Isocitrate Dehydrogenase [NADP] Mitochondrial (NADP(+)-Specific ICDH or Oxalosuccinate Decarboxylase or ICD M or IDP or IDH2 or EC 1.1.1.42) - Drugs in Development, 2021

US$ 3,000.00

Isocitrate Dehydrogenase [NADP] Mitochondrial (NADP(+)-Specific ICDH or Oxalosuccinate Decarboxylase or ICD M or IDP or IDH2 or EC 1.1.1.42) - Drugs in Development, 2021 SUMMARY Isocitrate Dehydrogena...

April 2021 35 pages

Janus Kinase (JAK or EC 2.7.10.2) - Drugs in Development, 2021

US$ 3,000.00

Janus Kinase (JAK or EC 2.7.10.2) - Drugs in Development, 2021 SUMMARY Janus Kinase (JAK or EC 2.7.10.2) - Drugs in Development, 2021 provides in depth analysis on Janus Kinase (JAK or EC 2.7.10.2) ta...

April 2021 50 pages

Juvenile Rheumatoid Arthritis (Immunology) - Drugs in Development, 2021

US$ 2,000.00

Juvenile Rheumatoid Arthritis (Immunology) - Drugs in Development, 2021 SUMMARY Juvenile Rheumatoid Arthritis (Immunology) - Drugs in Development, 2021 provides an overview of the Juvenile Rheumatoid...

April 2021 30 pages

Kappa Type Opioid Receptor (KOR1 or OPRK or OPRK1) - Drugs in Development, 2021

US$ 3,000.00

Kappa Type Opioid Receptor (KOR1 or OPRK or OPRK1) - Drugs in Development, 2021 SUMMARY Kappa Type Opioid Receptor (KOR1 or OPRK or OPRK1) - Drugs in Development, 2021 provides in depth analysis on Ka...

April 2021 170 pages

Kelch Like ECH Associated Protein 1 (Cytosolic Inhibitor Of Nrf2 or Inrf2 or Kelch Like Protein 19 or KEAP1) - Drugs in Development, 2021

US$ 3,000.00

Kelch Like ECH Associated Protein 1 (Cytosolic Inhibitor Of Nrf2 or Inrf2 or Kelch Like Protein 19 or KEAP1) - Drugs in Development, 2021 SUMMARY Kelch Like ECH Associated Protein 1 (Cytosolic Inhibit...

April 2021 30 pages

Kennedy’s Disease (Spinal and Bulbar Muscular Atrophy) (Genetic Disorders) - Drugs in Development, 2021

US$ 2,000.00

Kennedy’s Disease (Spinal and Bulbar Muscular Atrophy) (Genetic Disorders) - Drugs in Development, 2021 SUMMARY Kennedy’s Disease (Spinal and Bulbar Muscular Atrophy) (Genetic Disorders) - Drugs in De...

April 2021 30 pages

Keratoconjunctivitis (Ophthalmology) - Drugs in Development, 2021

US$ 2,000.00

Keratoconjunctivitis (Ophthalmology) - Drugs in Development, 2021 SUMMARY Keratoconjunctivitis (Ophthalmology) - Drugs in Development, 2021 provides an overview of the Keratoconjunctivitis pipeline la...

April 2021 30 pages

Ketohexokinase (Hepatic Fructokinase or KHK or EC 2.7.1.3) - Drugs in Development, 2021

US$ 3,000.00

Ketohexokinase (Hepatic Fructokinase or KHK or EC 2.7.1.3) - Drugs in Development, 2021 SUMMARY Ketohexokinase (Hepatic Fructokinase or KHK or EC 2.7.1.3) - Drugs in Development, 2021 provides in dept...

April 2021 30 pages

Kidney Disease (Nephropathy) (Genito Urinary System And Sex Hormones) - Drugs in Development, 2021

US$ 2,000.00

Kidney Disease (Nephropathy) (Genito Urinary System And Sex Hormones) - Drugs in Development, 2021 SUMMARY Kidney Disease (Nephropathy) (Genito Urinary System And Sex Hormones) - Drugs in Development,...

April 2021 115 pages

Klebsiella Infections (Infectious Disease) - Drugs in Development, 2021

US$ 2,000.00

Klebsiella Infections (Infectious Disease) - Drugs in Development, 2021 SUMMARY Klebsiella Infections (Infectious Disease) - Drugs in Development, 2021 provides an overview of the Klebsiella Infection...

April 2021 30 pages

Knee Osteoarthritis (Musculoskeletal Disorders) - Drugs in Development, 2021

US$ 2,000.00

Knee Osteoarthritis (Musculoskeletal Disorders) - Drugs in Development, 2021 SUMMARY Knee Osteoarthritis (Musculoskeletal Disorders) - Drugs in Development, 2021 provides an overview of the Knee Osteo...

April 2021 100 pages

Kynurenine 3 Monooxygenase (Kynurenine 3 Hydroxylase or KMO or EC 1.14.13.9) - Drugs in Development, 2021

US$ 3,000.00

Kynurenine 3 Monooxygenase (Kynurenine 3 Hydroxylase or KMO or EC 1.14.13.9) - Drugs in Development, 2021 SUMMARY Kynurenine 3 Monooxygenase (Kynurenine 3 Hydroxylase or KMO or EC 1.14.13.9) - Drugs i...

April 2021 30 pages

Lafora Disease (Unverricht Disease) (Central Nervous System) - Drugs in Development, 2021

US$ 2,000.00

Lafora Disease (Unverricht Disease) (Central Nervous System) - Drugs in Development, 2021 SUMMARY Lafora Disease (Unverricht Disease) (Central Nervous System) - Drugs in Development, 2021 provides an...

April 2021 30 pages

Laminin-Deficient Congenital Muscular Dystrophy (LAMA2 MD or LAMA2-Related Muscular Dystrophy) (Musculoskeletal Disorders) - Drugs in Development, 2021

US$ 2,000.00

Laminin-Deficient Congenital Muscular Dystrophy (LAMA2 MD or LAMA2-Related Muscular Dystrophy) (Musculoskeletal Disorders) - Drugs in Development, 2021 SUMMARY Laminin-Deficient Congenital Muscular Dy...

April 2021 30 pages

Large Conductance Mechanosensitive Channel (mscL) - Drugs in Development, 2021

US$ 3,000.00

Large Conductance Mechanosensitive Channel (mscL) - Drugs in Development, 2021 SUMMARY Large Conductance Mechanosensitive Channel (mscL) - Drugs in Development, 2021 provides in depth analysis on Larg...

April 2021 30 pages

Laryngeal Cancer (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Laryngeal Cancer (Oncology) - Drugs in Development, 2021 SUMMARY Laryngeal Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Laryngeal Cancer pipeline landscape. The report pr...

April 2021 75 pages

Lennox-Gastaut Syndrome (Central Nervous System) - Drugs in Development, 2021

US$ 2,000.00

Lennox-Gastaut Syndrome (Central Nervous System) - Drugs in Development, 2021 SUMMARY Lennox-Gastaut Syndrome (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Lennox-G...

April 2021 45 pages

Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis) (Oncology) - Drugs in Development, 2021 SUMMARY Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatos...

April 2021 55 pages

Letterer-Siwe Disease (Multifocal and multisystemic (disseminated) Langerhans-cell histiocytosis) (Genetic Disorders) - Drugs in Development, 2021

US$ 2,000.00

Letterer-Siwe Disease (Multifocal and multisystemic (disseminated) Langerhans-cell histiocytosis) (Genetic Disorders) - Drugs in Development, 2021 SUMMARY Letterer-Siwe Disease (Multifocal and multisy...

April 2021 30 pages

Leukocyte Immunoglobulin Like Receptor Subfamily B Member 2 (CD85 Antigen Like Family Member D or Immunoglobulin Like Transcript 4 or Monocyte/Macrophage Immunoglobulin Like Receptor 10 or CD85d or LILRB2) - Drugs in Development, 2021

US$ 3,000.00

Leukocyte Immunoglobulin Like Receptor Subfamily B Member 2 (CD85 Antigen Like Family Member D or Immunoglobulin Like Transcript 4 or Monocyte/Macrophage Immunoglobulin Like Receptor 10 or CD85d or LI...

April 2021 30 pages

Leukotriene B4 (LTB4) - Drugs in Development, 2021

US$ 3,000.00

Leukotriene B4 (LTB4) - Drugs in Development, 2021 SUMMARY Leukotriene B4 (LTB4) - Drugs in Development, 2021 provides in depth analysis on Leukotriene B4 (LTB4) targeted pipeline therapeutics. The re...

April 2021 35 pages

Lewy body Dementia (Central Nervous System) - Drugs in Development, 2021

US$ 2,000.00

Lewy body Dementia (Central Nervous System) - Drugs in Development, 2021 SUMMARY Lewy body Dementia (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Lewy body Dementia...

April 2021 65 pages

Limb-Girdle Muscular Dystrophy (Musculoskeletal Disorders) - Drugs in Development, 2021

US$ 2,000.00

Limb-Girdle Muscular Dystrophy (Musculoskeletal Disorders) - Drugs in Development, 2021 SUMMARY Limb-Girdle Muscular Dystrophy (Musculoskeletal Disorders) - Drugs in Development, 2021 provides an over...

April 2021 50 pages

Limbal Stem Cell Deficiency (LSCD) (Ophthalmology) - Drugs in Development, 2021

US$ 2,000.00

Limbal Stem Cell Deficiency (LSCD) (Ophthalmology) - Drugs in Development, 2021 SUMMARY Limbal Stem Cell Deficiency (LSCD) (Ophthalmology) - Drugs in Development, 2021 provides an overview of the Limb...

April 2021 30 pages

Lipase (EC 3.1.1.) - Drugs in Development, 2021

US$ 3,000.00

Lipase (EC 3.1.1.) - Drugs in Development, 2021 SUMMARY Lipase (EC 3.1.1.) - Drugs in Development, 2021 provides in depth analysis on Lipase (EC 3.1.1.) targeted pipeline therapeutics. The report prov...

April 2021 30 pages

Lipid Disorders (Metabolic Disorders) - Drugs in Development, 2021

US$ 2,000.00

Lipid Disorders (Metabolic Disorders) - Drugs in Development, 2021 SUMMARY Lipid Disorders (Metabolic Disorders) - Drugs in Development, 2021 provides an overview of the Lipid Disorders pipeline lands...

April 2021 35 pages

Lipodystrophy (Lipoatrophy) (Metabolic Disorders) - Drugs in Development, 2021

US$ 2,000.00

Lipodystrophy (Lipoatrophy) (Metabolic Disorders) - Drugs in Development, 2021 SUMMARY Lipodystrophy (Lipoatrophy) (Metabolic Disorders) - Drugs in Development, 2021 provides an overview of the Lipody...

April 2021 35 pages

Filters

Clear all